Innovative Treatment of Chemotherapy-Induced Painful Peripheral Neuropathy in Adolescents and Young Adults With Cancer: A Two Arm Pilot Study
Not Applicable
Recruiting
- Conditions
- Peripheral Neuropathy
- Interventions
- Device: Waitlist ST (Scrambler Therapy)Device: Immediate St (Scrambler Therapy)
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 38
- Registration Number
- NCT05357469
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling Approach
Withdrawn
- Conditions
- Brain Tumor
- First Posted Date
- 2022-05-02
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05356507
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Phase II Trial of Immunotherapy in Patients with Carcinomas Arising from the Renal Medulla
Phase 2
Active, not recruiting
- Conditions
- CarcinomasRenal Medullary Carcinoma
- Interventions
- First Posted Date
- 2022-04-26
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05347212
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
TAS-102 in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT05343013
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
A Comprehensive Clinical FMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
Recruiting
- Conditions
- Brain Tumor
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 1720
- Registration Number
- NCT05342454
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
Phase 2
Recruiting
- Conditions
- Malignant Plasma Cell NeoplasmMultiple MyelomaPlasma Cell Neoplasm
- Interventions
- Drug: Radiation Therapy
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05336383
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
Phase 2
Suspended
- Conditions
- Peritoneal MesotheliomaHodgkin's LymphomaPleural MesotheliomaSmall Cell Lung CancerNeuroendocrine CarcinomasCervical CarcinomaMicrosatellite High CancersExtrapulmonary High Grade
- Interventions
- Drug: XmAb20717
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 140
- Registration Number
- NCT05337735
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
Phase 2
Recruiting
- Conditions
- Urothelial CarcinomaMetastatic Cancer
- Interventions
- First Posted Date
- 2022-04-20
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05335941
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
First-in-Human Assessment of Safety, Biodistribution and Pharmacokinetics of 18F-Fluoro-1-Naphthol (18F-4FN) for PET Imaging
Phase 1
Active, not recruiting
- Conditions
- Endocrine Neoplasia
- Interventions
- Drug: 4-[18F]Fluoro-1-Naphthol
- First Posted Date
- 2022-04-19
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05335811
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Attitudes and Believes About Vaccinations in a Supportive Care Patient Population
Completed
- Conditions
- Vaccinations
- Interventions
- Other: patient population
- First Posted Date
- 2022-04-15
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 104
- Registration Number
- NCT05329506
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath